[1]蒋 俊,毛国庆.生信分析肾阳虚型绝经后骨质疏松症分子机制及淫羊藿的靶向治疗机制[J].医学信息,2023,36(04):21-26.[doi:10.3969/j.issn.1006-1959.2023.04.004]
　JIANG Jun,MAO Guo-qing.Bioinformatics Analysis of the Molecular Mechanism of Postmenopausal Osteoporosis with Kidney-yang Deficiency and the Targeted Treatment Mechanism of Epimedium Herb[J].Journal of Medical Information,2023,36(04):21-26.[doi:10.3969/j.issn.1006-1959.2023.04.004]
点击复制

生信分析肾阳虚型绝经后骨质疏松症分子机制及淫羊藿的靶向治疗机制()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年04期
页码:
21-26
栏目:
生物信息学
出版日期:
2023-02-15

文章信息/Info

Title:
Bioinformatics Analysis of the Molecular Mechanism of Postmenopausal Osteoporosis with Kidney-yang Deficiency and the Targeted Treatment Mechanism of Epimedium Herb
文章编号:
1006-1959（2023）04-0021-06
作者:
蒋 俊; 毛国庆
（南京中医药大学附属医院骨伤科，江苏 南京 210000）
Author(s):
JIANG Jun; MAO Guo-qing
(Department of Orthopedics,Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210000,Jiangsu,China)
关键词:
绝经后骨质疏松; 肾阳虚; 淫羊藿
Keywords:
Postmenopausal osteoporosis; Kidney-yang deficiency; Epimedium herb
分类号:
R285.5
DOI:
10.3969/j.issn.1006-1959.2023.04.004
文献标志码:
A
摘要:
目的 基于生物信息学方法探究肾阳虚型绝经后骨质疏松症的分子机制及淫羊藿的治疗靶点。方法 通过GEO挖掘阳虚型绝经后骨质疏松症患者与健康人群的差异基因，运用GeneCards及OMIM预测绝经后骨质疏松症靶点，通过匹配筛选出肾阳虚型绝经后骨质疏松症靶点；通过String构建蛋白互作网络，采用DAVID进行富集分析，利用分子对接预测淫羊藿治疗肾阳虚型骨质疏松症的靶点。结果 共得到差异基因509个，其中下调基因313个，上调基因196个；绝经后骨质疏松症靶点1187个，筛选得到阳虚型绝经后骨质疏松症靶点48个；GO富集分析这些靶点主要涉及细胞增殖、细胞迁移等生物过程，KEGG信号通路中差异基因主要富集于PI3K-Akt信号通路、Th17细胞分化等信号通路调节；分子对接显示淫羊藿3种有效成分槲皮素、木犀草素、山柰酚能够作用于EGF、CRP、FOS等核心蛋白。结论 肾阳虚型绝经后骨质疏松症可能主要由PI3K-Akt信号通路、Th17细胞分化等信号通路调控，淫羊藿可能靶向EGF、CRP等蛋白，通过PI3K-Akt、Th17细胞分化信号通路调节骨代谢，从而实现防治阳虚型绝经后骨质疏松症。
Abstract:
Objective To explore the molecular mechanism of postmenopausal osteoporosis with kidney-yang deficiency and the therapeutic target of epimedium herb based on bioinformatics methods.Methods The differential genes between postmenopausal osteoporosis patients with kidney-yang deficiency and healthy people were excavated by GEO, and the targets of postmenopausal osteoporosis were predicted by GeneCards and OMIM. The protein interaction network was constructed by String, and DAVID was used for enrichment analysis. Molecular docking was used to predict the target of epimedium herb in the treatment of osteoporosis with kidney-yang deficiency.Results A total of 509 differential genes were obtained, including 313 down-regulated genes and 196 up-regulated genes; 1187 targets for postmenopausal osteoporosis, and 48 targets for postmenopausal osteoporosis of kidney-yang deficiency were screened. GO enrichment analysis showed that these targets were mainly involved in biological processes such as cell proliferation and cell migration. The differential genes in KEGG signaling pathway were mainly enriched in PI3K-Akt signaling pathway and Th17 cell differentiation. Molecular docking showed that quercetin, luteolin and kaempferol could act on core proteins such as EGF, CRP and FOS.Conclusion Postmenopausal osteoporosis with kidney-yang deficiency may be mainly regulated by PI3K-Akt signaling pathway, Th17 cell differentiation and other signaling pathways. Epimedium herb may target EGF, CRP and other proteins to regulate bone metabolism through PI3K-Akt and Th17 cell differentiation signaling pathways, so as to prevent and treat postmenopausal osteoporosis with kidney-yang deficiency.

参考文献/References:

[1]中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华内分泌代谢杂志,2017,33(10):890-913.[2]中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.[3]连李荣,梁家畅,赵恒侠,等.中医药治疗围绝经期骨质疏松症用药规律的数据挖掘[J].广州中医药大学学报,2022,39(7):1703-1709.[4]马登磊,张兰,李林.淫羊藿提取物的抗炎作用及其机制[J].生物化学与生物物理进展,2020,47(8):685-699.[5]陈洁,金绍林.应用纳米银敷料联合表皮生长因子凝胶治疗小面积骨外露创面[J].生物医学工程与临床,2021,25(1):62-65.[6]张晨颖,石丹宁,赵丕文.基于GPER介导的EGFR/MEK/ERK途径探讨四物汤含药血清促进成骨细胞增殖的分子机制[J].中华中医药杂志,2022,37(9):5100-5103.[7]韩学明,孙忠良,徐建华,等.老年人血清炎症因子与骨密度变化及骨吸收相关性研究[J].中国骨质疏松杂志,2020,26(2):221-226.[8]孔劲松,阮建伟,黄杨,等.老年骨质疏松症患者骨代谢指标变化、生长分化因子15及其炎症因子水平分析[J].中国卫生检验杂志,2020,30(14):1710-1712.[9]Udagawa N,Koide M,Nakamura M,et al.Osteoclast differentiation by RANKL and OPG signaling pathways[J].J Bone Miner Metab,2021,39(1):19-26.[10]Liang L,Zhu DP,Guo SS,et al.MMP-1 gene polymorphism in osteoporosis[J].Eur Rev Med Pharmacol Sci,2019,23(3 Suppl):67-72.[11]朱伟,李伶,杨刚毅,等.重组人甲状旁腺素(1-34)对绝经后骨质疏松患者血基质金属蛋白酶1及其组织抑制因子的影响[J].中国新药与临床杂志,2011,30(1):20-23.[12]杨全增,张成俊,丁宁,等.ERK5信号通路介导流体剪切力对MC3T3-E1成骨细胞MMPs、TIMPs表达的影响[J].中国骨质疏松杂志,2018,24(5):588-593.[13]苏娟娟,朱永翠,张文玲.连翘苷对牙周炎大鼠p38 MAPK/c-Fos信号通路及破骨细胞活化的影响[J].口腔医学研究,2021,37(1):33-38.[14]Takayanagi H,Kim S,Matsuo K,et al.RANKL maintains bone homeostasis through c-Fos dependent induction of interferon-beta[J].Nature,2002,416(6882):744-749.[15]Xi JC,Zang HY,Guo LX,et al.The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis[J].J Recept Signal Transduct Res,2015,35(6):640-645.[16]Huang F,Wong P,Li J,et al.Osteoimmunology: The correlation between osteoclasts and the Th17/Treg balance in osteoporosis[J].J Cell Mol Med,2022,26(13):3591-3597. [17]Tang S,Xin Y,Yang M,et al.Osteoprotegerin promotes islet β cell proliferation in intrauterine growth retardation rats through the PI3K/AKT/FoxO1 pathway[J].International Journal of Clinical and Experimental Pathology,2019,12(6):2324-2338.[18]Tyagi AM,Srivastava K,Mansoori MN,et al.Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis[J].PLoS One,2012,7(9):e44552. [19]Wang N,Wang L,Yang J,et al.Quercetin promotes osteogenic differentiation and antioxidant responses of mouse bone mesenchymal stem cells through activation of the AMPK/SIRT1signaling pathway[J].Phytother Res,2021,35(5):612-622．[20]顾艺婧,傅稼耀,武文婧,等.槲皮素通过抗骨相关细胞衰老作用治疗雌激素缺乏骨质疏松症的初步研究[J].同济大学学报(医学版),2019,40(3):274-280．[21]Pang JL,Ricupero DA,Huang S,et al.Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells[J].Biochem Pharmacol,2006,71(6):818-826.[22]许勇,谢贤斐,颜威,等.木犀草素调控PI3K/AKT通路改善绝经后骨质疏松症大鼠模型骨丢失的机制 [J].热带医学杂志,2022,22(5):639-643,688,744.

更新日期/Last Update: 1900-01-01